Growing prevalence of blood disorders and chronic diseases
drives demand for coagulation testing.
WILMINGTON, Del., July 26, 2024 /PRNewswire/ -- The
global coagulation testing market is estimated to
flourish at a CAGR of 6.0% from 2024 to 2034. Transparency Market
Research projects that the overall sales revenue for coagulation
testing is estimated to reach US$
6.5 billion by the end of 2034. The increasing
number of surgical interventions, including complex procedures like
cardiac surgeries and organ transplants, drives demand for
coagulation testing to monitor patients' clotting status and reduce
bleeding risks.
As the global population ages, there is a growing need for
coagulation testing among the elderly population, who are at higher
risk of thrombotic events and coagulation disorders, driving market
expansion. Rapid economic development and improved healthcare
infrastructure in emerging markets lead to greater accessibility to
coagulation testing, fostering market growth and catering to
previously underserved populations.
Download Sample Copy of the Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=14168
The coagulation testing market is witnessing robust growth due
to the rising prevalence of liver diseases, cardiovascular
conditions, and blood disorders. According to the American Liver
Foundation, in the United States,
4.5 million adults (1.8%) have been diagnosed with liver disease.
In 2020, 51,642 adults in the U.S. died from liver disease, which
was the 12th leading cause of death.
Most of the important applications of these tests lie in the
diagnosis and monitoring of unexplained bleeding, management of
anticoagulant therapy, and assessment of the progression of liver
disease. Growing demand for effective diagnostic tools in these
areas is the market driver for expansion.
Today's discovery-oriented development includes exploring modern
and dynamic point-of-care (POC) solutions that can determine a
patient's coagulated status and be administered with all kinds of
anticoagulants, including direct oral anticoagulants, in the
shortest period. This is helping to ameliorate the patient's
outcome and make procedures easier on the clinical front. This
advancement has made point-of-care coagulation tests extremely
valuable for the early detection of bleeding disorders and close
monitoring of the effects of anticoagulant drugs. Vendors are
developing advanced POC solutions based on these applications.
Clotting factors in blood important to coagulation testing
include fibrinogen, prothrombin, thromboplastin, calcium, and
antihaemophilic factors. Prothrombin is an important plasma protein
always synthesized by the liver and is involved in coagulation. The
population aged 65 and above is increasing, which is prone to
cardiovascular and blood disorders.
Tests analyzing coagulation factors are very important in
testing diseases like bleeding disorders or clotting disorders.
These tests are performed to pinpoint the paucity of clotting
factors and the advancement of liver diseases or a scarcity of
vitamin K. An expected rise in demand is foreseen with the increase
in consumer awareness regarding coagulation disorders and the
rationale behind early diagnosis. In the meantime, a host of
research and development activities are ongoing to introduce
several more advanced and efficient coagulation-testing devices
equipped with efficiency.
Get Your PDF Brochure here:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=14168
Coagulation Testing Market Report Scope:
Report
Coverage
|
Details
|
Forecast
Period
|
2024-2034
|
Base
Year
|
2020-2022
|
Size in 2023
|
US$ 3.4 Bn
|
Forecast (Value) in
2034
|
US$ 6.5 Bn
|
Growth Rate
(CAGR)
|
6.0 %
|
No. of
Pages
|
177
Pages
|
Segments
covered
|
By Product Type, By
Test Type, By End-user, By Region
|
The rising preference for home-based healthcare solutions
prompts the development of portable and user-friendly coagulation
testing devices, enabling patients to monitor their clotting status
conveniently, thereby expanding the market reach. Increasing
emphasis on personalized medicine approaches drives the demand for
coagulation testing tailored to individual patient profiles,
facilitating targeted treatment strategies and optimizing
therapeutic outcomes.
Coagulation Testing Market: Competitive Landscape
In the competitive landscape of the coagulation testing market,
several key players vie for prominence. Industry leaders such as
Siemens Healthineers, F. Hoffmann-La Roche AG, and Abbott
Laboratories dominate with their comprehensive portfolios of
coagulation testing instruments and reagents.
Niche players like Sysmex Corporation and Helena Laboratories
contribute innovative solutions tailored to specific testing needs.
The market is characterized by intense research and development
activities focused on enhancing testing accuracy, efficiency, and
user-friendliness. Strategic collaborations, mergers, and
acquisitions further shape the competitive dynamics, as companies
strive to expand their market presence and meet the evolving
demands of healthcare providers and patients globally. Some
prominent players are as follows:
- Hoffmann-La Roche Ltd.
- Abbott
- Siemens Healthineers
- Sysmex Corporation
- Universal Biosensors Inc.
- HemoSonics LLC
- Thermo Fisher Scientific Inc.
- Randox Laboratories Ltd.
- Horiba, Ltd.
- Agappe Diagnostics Ltd.
- Medtronic
- Helena Laboratories Inc.
Product Portfolio
- Sysmex Corporation: Sysmex Corporation is a global
leader in in-vitro diagnostics, offering innovative solutions for
hemostasis and coagulation testing. Their product portfolio
includes automated coagulation analyzers and reagents, delivering
reliable and timely results to healthcare providers' worldwide,
ensuring optimal patient care.
- Universal Biosensors Inc.: Universal Biosensors
Inc. specializes in the development and manufacturing of innovative
biosensor technology for point-of-care diagnostic testing. Their
product portfolio includes rapid coagulation testing devices,
providing accurate and timely results for thrombosis and hemostasis
monitoring in clinical settings.
- HemoSonics LLC: HemoSonics LLC is dedicated to
revolutionizing critical care diagnostics with their proprietary
technology for assessing hemostasis. Their product portfolio
includes the Quantra Hemostasis Analyzer, offering rapid and
comprehensive coagulation testing solutions to aid clinical
decision-making in acute care settings.
Key Findings of the Market Report
- Consumables lead the coagulation testing market, driven by the
continuous demand for reagents, kits, and other consumables for
testing purposes.
- Prothrombin Time (PT) is leading the coagulation testing
market, providing crucial insights into the extrinsic clotting
pathway and coagulation status.
- Hospitals and clinics lead the coagulation testing market,
offering comprehensive diagnostic services and managing a wide
range of patient conditions.
Coagulation Testing Market Growth Drivers &
Trends
- Stringent regulations mandating coagulation testing for patient
safety and quality assurance drive market growth and demand for
testing solutions.
- Increasing preference for rapid and convenient testing methods
in healthcare settings fuels the adoption of point-of-care
coagulation testing devices.
- Growing investments in healthcare infrastructure and
diagnostics drive market expansion, supporting the procurement of
coagulation testing equipment and services.
- Increasing need for comprehensive coagulation panels that
assess multiple parameters simultaneously enhances market
opportunities for multiplex testing solutions.
- Heightened emphasis on accuracy and reliability in diagnostic
testing fosters demand for high-quality coagulation testing
products and services.
Global Coagulation Testing Market: Regional Profile
- In North America,
particularly the United States,
the market is driven by advanced healthcare systems and a high
prevalence of chronic diseases necessitating frequent
coagulation testing.
- Well-established diagnostic laboratories and hospitals
dominate, offering a wide array of testing services and products.
Stringent regulatory standards ensure the quality and reliability
of coagulation testing devices and reagents, fostering market
growth.
- Europe boasts a mature
coagulation testing market, led by countries like Germany, France, and the United Kingdom. Here, the market
benefits from robust healthcare infrastructure and extensive
research and development activities.
- Technological advancements in testing methods and a focus on
patient safety drive market expansion. Collaborations between
academic institutions and industry players further stimulate
innovation in coagulation testing solutions.
- In the Asia Pacific region,
rapid economic development and increasing healthcare expenditure
fuel market growth. Countries like China, India,
and Japan witness rising demand
for coagulation testing due to a growing burden of chronic diseases
and improving access to healthcare services.
- Local manufacturers and international players capitalize on
this trend by offering cost-effective testing solutions tailored to
the region's diverse healthcare needs.
Buy this Premium Research
Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=14168<ype=S
Coagulation Testing Market: Key Segments
By Product Type
By Test Type
- Prothrombin Time (PT)
- Activated Partial Thromboplastin Clotting Time (APTT)
- Thrombin Time (TT)
- Activated Clotting Time (ACT)
- Others
By End User
- Hospitals and Clinics
- Diagnostic Laboratories
- Home Care Settings
- Others
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East &
Africa
Explore More Trending Report by Transparency Market
Research:
- Wearable Heart Monitoring Devices Market Size to
Hit US$ 5.8 Billion, Globally, by
2031, Expanding at a CAGR of 12.5%
- Lactate Meter Market size was worth USD 141.3 Mn in 2022 and is expected to
reach USD 299.5 Mn by 2031 with a CAGR of
8.5%.
- Advanced Therapy Medicinal Products Market is projected
to advance at a CAGR of 16.6% from 2024 to 2034 and reach more than
US$ 245.1 Bn by the end of 2034.
About Transparency Market Research
Transparency Market Research, a global market
research company registered at Wilmington, Delaware, United States, provides custom research and
consulting services. Our exclusive blend of quantitative
forecasting and trends analysis provides forward-looking insights
for thousands of decision makers. Our experienced team of Analysts,
Researchers, and Consultants use proprietary data sources and
various tools & techniques to gather and analyses
information.
Our data repository is continuously updated and revised by a
team of research experts, so that it always reflects the latest
trends and information. With a broad research and analysis
capability, Transparency Market Research employs rigorous primary
and secondary research techniques in developing distinctive data
sets and research material for business reports.
Contact:
Transparency Market Research
Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West
Street,
Suite 1200, Wilmington, Delaware
19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free:
866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn | Twitter
| Blog | YouTube
Logo:
https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/coagulation-testing-market-to-reach-usd-6-5-billion-by-2034-surgical-interventions-aging-population-and-economic-growth-boost-demand--tmr-302207441.html